Funded Biotech startups in New York
14 biotech startups in New York have filed a Form D with the SEC and together report $504.8M raised. Immunic has the largest latest round, at $200M. Amounts are as reported on the filing, not estimates.
Updated Sep 8, 2026
- Companies
- 14
- Total raised
- $504.8M
- Filings
- 16
- Median round
- $7.5M
- Cities
- 4
CompanyCityLast filingLatest round
Hypercell TechnologiesOn-site food contamination tests with results in an hour
Ithaca
Sep 8, 2026
$3.0M
Cambrian BioPharmaDrugs that target the biology of aging
New York
Jun 30, 2026
$123.8M
MyrtelleGene therapy for Canavan disease
New York
Jun 22, 2026
$16.7M
Illuminare BiotechnologiesMyelin-binding dye that lights up nerves in surgery
Brooklyn
May 7, 2026
$3.6M
CresilonPlant-based gel that stops severe bleeding
Brooklyn
Apr 24, 2026
$29.0M
Bascule BiosciencesDevelopment-led oncology company that acquires…
New Rochelle
Mar 25, 2026
$250K
AtommapProtein motion simulation for small-molecule drug design
New York
Mar 6, 2026
$31.1M
Inso BiosciencesMicrofluidic DNA extraction for long-read sequencing
Ithaca
Mar 3, 2026
$750K
ImmunicOral drugs for multiple sclerosis and colitis
New York
Feb 17, 2026
$200.0M
MedicovestorDimeric antibody-drug conjugates for low-antigen tumors
New York
Nov 5, 2025
$3.2M
ValthosAI for detecting biothreats and designing countermeasures
New York
Aug 14, 2025
$27.3M
Barnwell BioLivestock disease monitoring from farm waste streams
New York
Apr 4, 2025
$6.1M
Episteme PrognosticsTest predicting chemo response in pancreatic cancer
Brooklyn
Feb 21, 2025
$550K
Liberation LabsCommercial-scale precision fermentation manufacturing
New York
Jan 28, 2025
$52.0M
All 14 companies · most recent filing first
Most recent filings
14All 14 companies · most recent filing first